BioWorld

Aug. 18, 2006

View Archived Issues

Acologix Hopes To Bring In $115M On Tokyo Exchange

With Japanese investors holding the majority of its shares and a lead product in-licensed from a Tokyo-based company, Acologix Inc. filed to conduct a $115 million initial public offering on the Tokyo Stock Exchange. (BioWorld Today) Read More

Biotechs Should Benefit When Leadership Atop FDA Finalized

Read More

Researchers Link P53 Tumor Suppressor To Angiogenesis

Read More

Accera's Alzheimer's Work Boosted By $7.5M Series B

Read More

Clinic Roundup

Read More

Other News To Note

Read More